Invasive disease‐free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor‐positive, <scp>HER2</scp>‐negative early breast cancer treated with upfront letrozole: Experiences from the phase <scp>IV PreFace</scp> trial

Milena Beierlein, Lothar Häberle, Naiba Nabieva, Nicolai Maass, Bahriye Aktas, Sherko Kümmel, Christoph Thomssen, Christopher Wolf, Hans‐Christian Kolberg, Cosima Brucker, Wolfgang Janni, Peter Dall, Andreas Schneeweiss, Frederik Marme, Marc W. Sütterlin, Matthias Ruebner, Anna‐Katharin Theuser, Nadine M. Hofmann, Sybille Böhm, Katrin Almstedt, Sara Kellner, Paul Gass, Hans‐Joachim Lück, Alexander Hein, Sabine Schmatloch, Matthias Kalder, Christoph Uleer, Ingolf Juhasz‐Böss, Volker Hanf, Christian Jackisch, Volkmar Müller, Brigitte Rack, Erik Belleville, Diethelm Wallwiener, Achim Rody, Claudia Rauh, Chistian M. Bayer, Sabrina Uhrig, Hanna Huebner, Chloë Goossens, Sara Y. Brucker, Carolin C. Hack, Tanja N. Fehm, Peter A. Fasching

Open source

DOI: 10.1002/ijc.70037
Published: 2025-07-11
Container: International Journal of Cancer
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/ijc.70037,
  title = {Invasive disease‐free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor‐positive, <scp>HER2</scp>‐negative early breast cancer treated with upfront letrozole: Experiences from the phase <scp>IV PreFace</scp> trial},
  author = {Milena Beierlein and Lothar Häberle and Naiba Nabieva and Nicolai Maass and Bahriye Aktas and Sherko Kümmel and Christoph Thomssen and Christopher Wolf and Hans‐Christian Kolberg and Cosima Brucker and Wolfgang Janni and Peter Dall and Andreas Schneeweiss and Frederik Marme and Marc W. Sütterlin and Matthias Ruebner and Anna‐Katharin Theuser and Nadine M. Hofmann and Sybille Böhm and Katrin Almstedt and Sara Kellner and Paul Gass and Hans‐Joachim Lück and Alexander Hein and Sabine Schmatloch and Matthias Kalder and Christoph Uleer and Ingolf Juhasz‐Böss and Volker Hanf and Christian Jackisch and Volkmar Müller and Brigitte Rack and Erik Belleville and Diethelm Wallwiener and Achim Rody and Claudia Rauh and Chistian M. Bayer and Sabrina Uhrig and Hanna Huebner and Chloë Goossens and Sara Y. Brucker and Carolin C. Hack and Tanja N. Fehm and Peter A. Fasching},
  year = {2025},
  journal = {International Journal of Cancer},
  doi = {10.1002/ijc.70037},
  url = {https://doi.org/10.1002/ijc.70037}
}

RIS

TY  - JOUR
TI  - Invasive disease‐free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor‐positive, <scp>HER2</scp>‐negative early breast cancer treated with upfront letrozole: Experiences from the phase <scp>IV PreFace</scp> trial
AU  - Milena Beierlein
AU  - Lothar Häberle
AU  - Naiba Nabieva
AU  - Nicolai Maass
AU  - Bahriye Aktas
AU  - Sherko Kümmel
AU  - Christoph Thomssen
AU  - Christopher Wolf
AU  - Hans‐Christian Kolberg
AU  - Cosima Brucker
AU  - Wolfgang Janni
AU  - Peter Dall
AU  - Andreas Schneeweiss
AU  - Frederik Marme
AU  - Marc W. Sütterlin
AU  - Matthias Ruebner
AU  - Anna‐Katharin Theuser
AU  - Nadine M. Hofmann
AU  - Sybille Böhm
AU  - Katrin Almstedt
AU  - Sara Kellner
AU  - Paul Gass
AU  - Hans‐Joachim Lück
AU  - Alexander Hein
AU  - Sabine Schmatloch
AU  - Matthias Kalder
AU  - Christoph Uleer
AU  - Ingolf Juhasz‐Böss
AU  - Volker Hanf
AU  - Christian Jackisch
AU  - Volkmar Müller
AU  - Brigitte Rack
AU  - Erik Belleville
AU  - Diethelm Wallwiener
AU  - Achim Rody
AU  - Claudia Rauh
AU  - Chistian M. Bayer
AU  - Sabrina Uhrig
AU  - Hanna Huebner
AU  - Chloë Goossens
AU  - Sara Y. Brucker
AU  - Carolin C. Hack
AU  - Tanja N. Fehm
AU  - Peter A. Fasching
PY  - 2025
JO  - International Journal of Cancer
DO  - 10.1002/ijc.70037
UR  - https://doi.org/10.1002/ijc.70037
ER  -

APA

Beierlein, M., Häberle, L., Nabieva, N., Maass, N., Aktas, B., Kümmel, S., Thomssen, C., Wolf, C., Kolberg, H., Brucker, C., Janni, W., Dall, P., Schneeweiss, A., Marme, F., Sütterlin, M. W., Ruebner, M., Theuser, A., Hofmann, N. M., Böhm, S., Almstedt, K., Kellner, S., Gass, P., Lück, H., Hein, A., Schmatloch, S., Kalder, M., Uleer, C., Juhasz‐Böss, I., Hanf, V., Jackisch, C., Müller, V., Rack, B., Belleville, E., Wallwiener, D., Rody, A., Rauh, C., Bayer, C. M., Uhrig, S., Huebner, H., Goossens, C., Brucker, S. Y., Hack, C. C., Fehm, T. N., & Fasching, P. A. (2025). Invasive disease‐free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor‐positive, <scp>HER2</scp>‐negative early breast cancer treated with upfront letrozole: Experiences from the phase <scp>IV PreFace</scp> trial. International Journal of Cancer. https://doi.org/10.1002/ijc.70037

Source records

crossref · retrieved 2026-09-27T11:20:12.054Z